Registry of Lobbyists
Subject matters | Details | Categories |
---|---|---|
Federal-Provincial Relations,
Health,
Research and Development
|
Bill C-64, An Act respecting pharmacare (Pharmacare Act)
|
Legislative Proposal, Bill or Resolution
|
Health,
Research and Development,
Science and Technology
|
Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.
|
Legislative Proposal, Bill or Resolution
|
International Trade
|
Free trade treaty agreement as it relates to the Canada US Free Trade Agreement (CUSMA) and free trade negotiations as it relates to Columbia, India, and the European Union.
|
Policies or Program
|
Health,
Intellectual Property
|
Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business.
|
Regulation
|
Health,
Intellectual Property,
Science and Technology
|
Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.
|
Legislative Proposal, Bill or Resolution
|
Health,
Industry,
Intellectual Property
|
Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.
|
Regulation
|
Industry,
Intellectual Property,
Taxation and Finance
|
Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy.
|
Policies or Program
|
Health,
Science and Technology
|
The government's Science and Technology Strategy potential policies & programs pertaining to the biopharmaceutical industry.
|
Policies or Program
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Free trade treaty agreement as it relates to the Canada US Free Trade Agreement (CUSMA) and free trade negotiations as it relates to Columbia, India, and the European Union.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business.
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
The government's Science and Technology Strategy potential policies & programs pertaining to the biopharmaceutical industry.
|
Policies or Program
|
Communication techniques that have been used or are expected to be used in the course of the undertaking: